Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

E-ISSN： 1529-0131|62|12|3607-3614

ISSN： 0004-3591

Source： Arthritis & Rheumatism, Vol.62, Iss.12, 2010-12, pp. : 3607-3614

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells

By Juliàà Antonio Barcelóó Mireia Erra Alba Palacio Carles Marsal Sara

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1697-1708

Future Medicine

Access to resources Recommend Favorite

Durability and Rapidity of Response to Anakinra in Patients with Rheumatoid Arthritis

By Michael H. Schiff

Drugs, Vol. 64, Iss. 22, 2004-01 ,pp. : 2493-2501

Adis International

Access to resources Recommend Favorite

Research Highlights: Clinical relevance of the type I interferon signature in multiple sclerosis

By Verweij Cornelis L

Pharmacogenomics, Vol. 13, Iss. 16, 2012-12 ,pp. : 1883-1885

Future Medicine

Access to resources Recommend Favorite

Rituximab has the right moves in rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Statins inhibit rituximab effect in rheumatoid arthritis

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite